Log in

CTSO Cytosorbents Corp NASDAQ · United States

Cytosorbents (CTSO) news

Cytosorbents Corp is a public biotech or pharmaceutical company listed on NASDAQ under the ticker CTSO, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Cytosorbents news

We have not published a story on Cytosorbents yet. When there is news, it will appear here.

Cytosorbents annual financials

LineFY2025FY2024
Net income (loss)-$8.2 million-$20.7 million
Cash from operations-$12.4 million-$14.4 million
Cash and equivalents$6.2 million$3.3 million

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $4.4 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about Cytosorbents

What is the ticker symbol of Cytosorbents?

Cytosorbents Corp trades under the ticker CTSO on NASDAQ.

Where is Cytosorbents listed?

Cytosorbents Corp is listed on NASDAQ.

Which country or territory is Cytosorbents listed under?

Our directory records Cytosorbents Corp under United States.

Does aibio.space cover Cytosorbents?

aibio.space lists Cytosorbents Corp among 2,820 public biotech companies and publishes its news here as stories appear.

Is Cytosorbents profitable?

Cytosorbents Corp reported a net loss of $8.2 million for the fiscal year ended Dec 31, 2025, and used $12.4 million of cash in operations, per its annual report to the SEC.

How much cash does Cytosorbents have?

$4.4 million in cash at Jun 30, 2026, per its 10-Q.

Investor discussion: Cytosorbents

Members talk about Cytosorbents (CTSO). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Cytosorbents, newest first. Each line links the filing it comes from.

  1. Listings

    Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 7.01,8.01,9.01). Source

  2. Listings

    Reported a reverse stock split. SEC Form 8-K (Items 5.03,9.01). Source

  3. Listings

    Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.07). Source

  4. Listings

    Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). Source

  5. Listings

    Asked shareholders to approve a reverse stock split. SEC Form DEF 14A. Source

  6. Listings

    Asked shareholders to approve a reverse stock split. SEC Form PRE 14A. Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:CTSO on TradingView.

Listing details

Cytosorbents Corp is a public biotech or pharmaceutical company listed on NASDAQ under the ticker CTSO, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Cytosorbents Corp
Ticker
CTSO
Listing
NASDAQ
Country or territory
United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.